BiO2 Medical's combined triple lumen/IVC Filter marketed as the Angel™ Catheter receives CE Mark, and will be introduced at the United Kingdom Intensive Care Society's 'State of the Art' Meeting

SAN ANTONIO, Dec. 9, 2012 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is pleased to announce CE Mark approval for the triple lumen Angel™ Catheter.  The Angel™ Catheter is a Nitinol, Inferior Vena Cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing Pulmonary Embolism (PE) in critically ill patients.  Placed at the patient's bedside without the need for fluoroscopy, the Angel™ Catheter provides instant protection from PE and is the first IVC Filter to receive CE Mark approval for prophylactic indications.

BiO2 Medical will introduce the Angel™ Catheter in the United Kingdom, with an exhibition booth at the UK Intensive Care Society's 'State of the Art' Meeting in London, England from December 10-12, 2012.  BiO2 Medical is sponsoring a lunch symposium on Tuesday, December 11th, 2012, at the 'State of the Art' meeting entitled, "Improved PE Prevention in the ITU: Angel™ Catheter-Bedside IVC Filter Prophylaxis." Chairing the symposium will be Dr. Max Jonas , Consultant Anesthetist and Intensivist at Southampton University Hospital in Southampton, UK.  Speaking at the lunch symposium will be Dr. Andy Eynon , Director of Major Trauma & Neuro Intensive Care Consultant at Southampton University Hospital in Southampton, UK, and BiO2  Medical's Chief Medical Officer, Dr. Luis Angel , inventor of the Angel™ Catheter and Associate Professor of Pulmonary and Critical Care Medicine at the University of Texas Health Science Center in San Antonio, Texas. 

According to Christopher E. Banas , BiO2 Medical's Chairman and Chief Executive Officer, "This represents an important milestone for BiO2 Medical and the commercialization of the Angel™ Catheter.  We are pleased to provide physicians with a technology that offers immediate Pulmonary Embolism protection for ICU patients during the critical unprotected window, while simultaneously allowing for lifesaving fluid and medication administration."

BiO2 Medical is a medical device manufacturer founded to design, develop, and subsequently manufacture a range of medical products in response to clinical needs.  For more information regarding BiO2 Medical and the Angel™ Catheter, please visit www.bio2medical.com.

SOURCE BiO2 Medical, Inc.

RELATED LINKS
http://www.bio2medical.com